Dr Peter R Carroll Mph Md - Reviews

Dr. Carroll is on Doximity

As a Doximity member you'll join over a meg verified healthcare professionals in a private, secure network.

• Connect with other colleagues in the aforementioned infirmary or clinic
• Search all U.S. specialist profiles and refer a patient
• Read the latest clinical news and earn CME/CEU credits

See Dr. Carroll's total profile

Already accept an business relationship?

• Office

• Is this information wrong?

Education & Training

• 

  New York Presbyterian Hospital Residency, Urology, 1984 - 1986

• 

  Academy of California (San Francisco) Schoolhouse of Medicine Residency, Urology, 1981 - 1984

• 

  University of California (San Francisco) School of Medicine Residency, Surgery, 1979 - 1981

• 

  Georgetown University School of Medicine Class of 1979

Certifications & Licensure

• 

  CA State Medical License 1980 - 2023

• American Lath of Urology Urology

Awards, Honors, & Recognition

• America's Meridian Doctors Castle Connolly, 2002-2014
• America's Elevation Doctors for Cancer Castle Connolly, 2005-2013
• CMS Meaningful Apply Stage 1 Certification EpicCare Convalescent EMR, Epic Systems Corporation, 2012-2013
• Top MD Consumers Checkbook
• Super Physician SuperDoctors.com
• Fellow (FACS) American College of Surgeons
• Join now to come across all

Clinical Trials

• Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Start of enrollment: 1996 Dec 01
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage Iii Colon Cancer Start of enrollment: 2004 Feb 01
• Lycopene or Omega-3 Fatty Acrid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer Start of enrollment: 2003 Apr 01
• BETH Study: Treatment of HER2 Positive Chest Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab Start of enrollment: 2008 April 01
• Nutrition and Lifestyle Changes in Patients With Previously Untreated Phase I or Phase Ii Prostate Cancer Commencement of enrollment: 2003 Sep 01
• Prostate Agile Surveillance Report Start of enrollment: 2008 Jul 01

  Recruiting

• S0931, Everolimus in Treating Patients With Kidney Cancer Who Accept Undergone Surgery Get-go of enrollment: 2011 Apr 01

  Active, non recruiting

  Stage 3

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Claret Units (CBUs) Start of enrollment: 2011 Oct 01

  Recruiting

• A Written report of Intra-operative Autologous Retropubic Urethral Sling on Urinary Control After Robot Assisted Radical Prostatectomy Start of enrollment: 2013 Apr 01
• Streamlining Trauma Enquiry Evaluation With Advanced Measurement Start of enrollment: 2022 Jan 01

  Completed

• Crizotinib in Treating Patients With Stage IB-IIIA Non-modest Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) Beginning of enrollment: 2022 Aug 18
• Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model Kickoff of enrollment: 2022 Mar 25
• Web-based Lifestyle Trial Amidst Men With Prostate Cancer: Prostate viii Starting time of enrollment: 2022 Jun 01
• CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer Outset of enrollment: 2022 Jul 18

  Active, not recruiting

  Not Applicable

• [18F]FTC-146 PET/MRI in Healthy Volunteers and in CRPS and Sciatica Start of enrollment: 2022 February 09
• Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer Start of enrollment: 2022 Nov 01

  Completed

  Stage two, Phase 3

• Join now to see all

Publications & Presentations

PubMed

• 1 citations

  Identification of prostate cancer using multiparametric MR imaging characteristics of prostate tissues referenced to whole mount histopathology.

  Matthew Gibbons, Olga Starobinets, Jeffry P. Simko, John Kurhanewicz, Peter R. Carroll, Susan G. Noworolski> ;Magnetic Resonance Imaging. 2022 Jan 1

• Comparison of Characteristics, Follow-upward and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database

  Kerri Beckmann, Aida Santaolalla, Jozien Helleman, Peter R. Carroll, Byung Ha Chung, Lui Shiong Lee, Antoinette S. Perry, José Rubio-Briones, Mikio Sugimoto, Bruce J. ...> ;European urology open science. 2022 Dec 1
• 1 citations

  Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Handling

  Yu Jiang, Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki, Irene Helenowski, Linda Kachuri, Daniel W. Lin, Janet L. Stanford...> ;HGG advances. 2022 Nov 18

• Evaluating the Outcomes of Agile Surveillance in Grade Group 2 Prostate Cancer: Prospective Results From the Canary PASS Cohort.

  Adrian J. Waisman Malaret, Peter Chang, Kehao Zhu, Yingye Zheng, Lisa F. Newcomb, Menghan Liu, Jesse K. McKenney, James D. Brooks, Peter R. Carroll, Atreya Dash, Chris...> ;The Periodical of Urology. 2022 Nov 11
• 17 citations

  Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospectiv...

  Thomas A. Hope, Matthias Eiber, Wesley R Armstrong, Roxanna Juarez, Vishnu Murthy, Courtney Lawhn-Heath, Spencer C. Behr, Li Zhang, Francesco Barbato, Francesco Ceci, ...> ;JAMA Oncology. 2022 Nov 1
• 1 citations

  Androgen Impecuniousness Therapy and the Risk of Dementia after Handling for Prostate Cancer.

  Peter E. Lonergan, Samuel Fifty. WashingtonIII, Janet E. Cowan, Shoujun Zhao, Jeanette 1000. Broering, Matthew R. Cooperberg, Peter R. Carroll> ;The Periodical of Urology. 2022 October 31
• 1 citations

  Treatment in the absence of illness reclassification among men on agile surveillance for prostate cancer

  Peter Due south. Kirk, Kehao Zhu, Yingye Zheng, Lisa F. Newcomb, Jeannette M. Schenk, James D. Brooks, Peter R. Carroll, Atreya Dash, William J. Ellis, Christopher P. Filson, ...> ;Cancer. 2022 Sep 13
• ane citations

  Agile surveillance in intermediate-risk prostate cancer with PSA ten-twenty ng/mL: pathological outcome analysis of a population-level database.

  Peter E. Lonergan, Chang Wook Jeong, Samuel L. Washington, Annika Herlemann, Scarlett Lin Gomez, Peter R. Carroll, Matthew R. Cooperberg> ;Prostate Cancer and Prostatic Diseases. 2022 Sep 10

• Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary accomplice.

  Peter E. Lonergan, Janet E. Cowan, Samuel 50. Washington, Scott A. Greenberg, Hao G. Nguyen, Peter R. Carroll> ;The Prostate. 2022 Sep one

• Private Patient Data Meta-analysis of Discrimination of the Four Kallikrein Console Associated With the Inclusion of Prostate Volume.

  Emily Vertosick, Stephen M. Zappala, Sanoj Punnen, Jonas Hugosson, Stephen A. Boorjian, Alexander Haese, Peter R. Carroll, Matthew R. Cooperberg, Anders Bjartell, Hans...> ;Urology. 2022 Aug 24
• one citations

  Association of Historic period With Hazard of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Agile Surveillance

  Claire Grand. de la Calle, Kevin Shee, Carissa Chu, Janet Eastward. Cowan, Hao G. Nguyen, Peter R. Carroll> ;Urology. 2022 Jun nine
• 2 citations

  A bicentric retrospective assay of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it he...

  Ali Salavati, Mehmet Gencturk, Yasemin Koksel, Allyssa Due north. Schik, Peter R. Carroll, Felix Y. Feng, Steven P. Rowe, Courtney Lawhn-Heath, Thomas A. Promise, Jerry W. Froelich> ;European Periodical of Nuclear Medicine and Molecular Imaging. 2022 Jun 6
• three citations

  Adjuvant Versus Early on Salvage Radiation Therapy for Men at Loftier Gamble for Recurrence Post-obit Radical Prostatectomy for Prostate Cancer and the Gamble of Death

  Derya Tilki, Ming-Hui Chen, Jing Wu, Hartwig Huland, Markus Graefen, Thomas Wiegel, Dirk Böhmer, Osama Mohamad, Janet E. Cowan, F.Y. Feng, Peter R. Carroll, Bruce J. T...> ;Periodical of Clinical Oncology. 2022 Jun iv

• Cell-Gratuitous DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing

  Emmalyn Chen, Clinton L. Cario, Lancelote Leong, Karen Lopez, Cesar P Marquez, Patricia Li, Erica Oropeza, Imelda Tenggara, Janet Due east. Cowan, Jeffry P. Simko, Robin Kage...> ;JCO precision oncology. 2022 Apr 27
• 1 citations

  Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen.

  Scott A. Greenberg, Samuel 50. Washington, Peter Due east. Lonergan, Janet E. Cowan, Avi Baskin, Hao G. Nguyen, Anobel Y. Odisho, Jeffry P. Simko, Peter R. Carroll> ;The Periodical of Urology. 2022 Apr 27
• xi citations

  SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional ...

  Martina Maggi, Francesco Del Giudice, Ugo Falagario, Andrea Cocci, Giorgio Ivan Russo, Marina Di Mauro, Giuseppe Salvatore Sepe, Fabio Galasso, Rosario Leonardi, Gabri...> ;Cancers. 2022 Apr 23
• 13 citations

  Biomarkers in Prostate Cancer Diagnosis: From Current Noesis to the Role of Metabolomics and Exosomes.

  Stefano Salciccia, Anna Laura Capriotti, Aldo Laganà, Stefano Fais, Mariantonia Logozzi, Ettore De Berardinis, Gian Maria Busetto, Giovanni Battista Di Pierro, Gian Pi...> ;International Periodical of Molecular Sciences. 2022 April 22

• Mail service-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history

  Crystal S. Langlais, June M. Chan, Stacey A. Kenfield, Janet E. Cowan, Rebecca E. Graff, Jeanette Grand. Broering, Peter R. Carroll, Erin Fifty. Van Blarigan> ;Cancer Causes & Control. 2022 Apr 9
• 1 citations

  Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Principal Prostate Cancer

  Carissa Chu, Mohammed Alshalalfa, Martin Sjöström, Shuang Grand. Zhao, Yang Liu, Jonathan Chou, Annika Herlemann, Brandon A. Mahal, Amar U. Kishan, Daniel E. Spratt, Matth...> ;European Urology. 2022 Apr 8
• three citations

  Multicenter Comparison of 17-Cistron Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate C...

  Jennifer Cullen, Julie Lynch, Eric A. Klein, Stephen K. Van Den Eeden, Peter R. Carroll, James Fifty. Mohler, Dejan Knezevic, Thomas A. Farrington, Ruixiao Lu> ;The Journal of Urology. 2022 April 1
• 2 citations

  Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus

  Wei Phin Tan, Ardeshir R. Rastinehad, Laurence Klotz, Peter R. Carroll, Mark Emberton, John F Feller, Arvin 1000. George, Inderbir Southward. Gill, Rajan T. Gupta, Aaron E. Katz,...> ;Urologic Oncology-seminars and Original Investigations. 2022 Mar 4
• 6 citations

  Cell-free Dna concentration and fragment size as a biomarker for prostate cancer.

  Emmalyn Chen, Clinton L. Cario, Lancelote Leong, Karen Lopez, Cesar P Marquez, Carissa Chu, Patricia Li, Erica Oropeza, Imelda Tenggara, Janet E. Cowan, Jeffry P. Simk...> ;Scientific Reports. 2022 Mar iii
• two citations

  Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy.

  Carissa Chu, Lauren Law, Kyle Zuniga, Tracy Kuo Lin, Candy Tsourounis, Rosa Rodriguez-Monguio, Ann A. Lazar, Samuel L. Washington, Matthew R. Cooperberg, Kirsten Green...> ;Urology. 2022 Mar ane
• 25 citations

  A Systematic Review of the Testify for the Decipher Genomic Classifier in Prostate Cancer.

  Neil K. Jairath, Alan Dal Pra, Randy Vince, Robert T. Dess, William C. Jackson, Jeffrey J. Tosoian, Sean McBride, Shuang G. Zhao, Alejandro Berlin, Brandon A. Mahal, A...> ;European Urology. 2022 Mar 1
• 38 citations

  A Phase 2/3 Prospective Multicenter Written report of the Diagnostic Accurateness of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).

  Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Frédéric Pouliot, Stephan Probst, Lawrence Saperstein, Mark A. Preston, Ajjai Alva, Akash Patnai...> ;The Journal of Urology. 2022 Feb 26
• Join now to meet all

Journal Manufactures

• Offset-in-Man Phase I Study of CTT1057, a Novel 18F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer

  Spencer C Behr, Hao Yard Nguyen, Thomas A Promise, Kirsten L Greene, Matthew R Cooperberg, Robert R Flavell, Eric J Small, Peter R Carroll, Journal of Nuclear Medicine

Lectures

• AUA Education Workshop for Program Directors and Chairpersons

  American Urological Association, Linthicum, Maryland - ii/9/2013

Printing Mentions

• 

  Delaying RP with Active Surveillance Carries No Greater Risks September 14th, 2015

• 

  'Screening Smarter' for Prostate Cancer March 23rd, 2018

• 

  Experimental Treatment Is 'Achilles Heel' for Aggressive Prostate Tumors May 3rd, 2018

• Join now to come across all

Grant Support

• Effectiveness Of Early Stage Prostate Cancer Treatment National Cancer Institute 2009–2010
• MALE Reproductive Health Research Career Development Plan Eunice Kennedy Shriver National Institute Of Kid Health &Human Development 2006–2010
• UCSF Prostate Cancer Spore National Cancer Plant 2004–2008
• Molecular Furnishings Of Nutrition Supplements In Prostate National Cancer Institute 2005–2007
• Active Surveillance For Early on Stage Prostate Cancer: Selection, Monitoring National Cancer Establish 2006

Professional Memberships

• Member

Hospital Affiliations

• 

  UCSF Medical Center San Francisco, California

• 

• 

• Viewing the total contour is available to verified healthcare professionals merely.

• Find your profile and take command of your online presence:

coonwilegire.blogspot.com

Source: https://www.doximity.com/pub/peter-carroll-md-ce1909cf

Share this post